How Are Leading Providers Integrating the EMTT-Shockwave Combined Approach?
As regenerative medicine continues to evolve, healthcare providers are increasingly adopting the EMTT-Shockwave combined approach to improve patient outcomes and expand treatment capabilities.
But successful integration requires more than access to technology; it requires clinical insight and real-world application strategies.
In an educational webinar from our ongoing series, Dr. Brice Blatz, MD, covers this topic in detail and shares how he integrates Extracorporeal Shockwave Therapy (ESWT/EPAT®) and Extracorporeal Magnetotransduction Therapy (EMTT®) into his regenerative medicine practice.
This blog highlights key takeaways from that engaging, informative session and how providers can apply them.
Top 3 Takeaways from Dr. Blatz on EMTT-Shockwave Integration
- Combination therapy enhances outcomes: Shockwave therapy and EMTT address both mechanical and cellular healing processes
- Integration supports practice growth: Offering both technologies increases patient demand and case value
- Education is essential: Clinical success depends on structured onboarding and treatment protocols
What Does the EMTT-Shockwave Combined Approach Look Like in Practice?
In his regenerative medicine practice, Dr. Blatz utilizes the EMTT-Shockwave combined approach across a wide spectrum of musculoskeletal (MSK) conditions.
His approach is grounded in leveraging the complementary effects of each modality:
Shockwave Therapy (EPAT®/ESWT)
- Mechanical stimulation of tissue
- Promotion of blood flow and neovascularization
- Support for tissue remodeling
- Pain modulation
Extracorporeal Magnetotransduction Therapy (EMTT®)
- Cellular signaling enhancement
- Anti-inflammatory effects
- Support for bone and soft tissue healing
As Dr. Blatz explains, these technologies work together to help “re-educate” dysfunctional tissue and improve healing at multiple levels.
Which Conditions Does Dr. Blatz Treat with EMTT-Shockwave?
According to Dr. Blatz, the EMTT-Shockwave combined approach is highly versatile and effective across:
Soft Tissue Conditions
- Tendinopathies
- Myofascial tissue dysfunction and trigger points
- Muscle injuries
- Ligament conditions
Bone and Joint Conditions
- Delayed unions and nonunions
- Bone marrow lesions
- Degenerative joint conditions
Pre- and Post-Surgical Applications
- Preparing tissue before surgery
- Supporting recovery and rehabilitation
His experience highlights how combining modalities can expand treatment options for both acute and chronic presentations and deliver accelerated, optimized healing outcomes.
Why Does the EMTT-Shockwave Combined Approach Improve Outcomes?
Dr. Blatz emphasizes that combining modalities allows providers to address both symptoms and underlying tissue dysfunction.
Providers using this approach commonly observe:
- Reduction in pain levels
- Improved function and mobility
- Faster return-to-activity timelines
- Enhanced tissue healing response
Clinical Insight from Dr. Blatz
“When you combine these technologies, you’re not just treating pain, you’re influencing the tissue environment in a meaningful way.”
This dual-level effect is a key advantage of the EMTT-Shockwave combined approach.
How Does EMTT-Shockwave Integration Support Practice Growth?
Beyond clinical outcomes, Dr. Blatz highlights the impact on practice performance and growth.
Key Benefits for Providers
- Attracts patients seeking non-invasive regenerative solutions
- Expands treatment offerings and case acceptance
- Increases revenue per patient through comprehensive care plans
- Differentiates the practice in a competitive market
Practices implementing this approach often see:
- Increased patient retention
- Higher referral rates
- Stronger positioning as leaders in regenerative medicine
What are the Best Practices for Integration?
A key theme in Dr. Blatz’s clinical approach is that technology alone does not determine outcomes; implementation does.
Core Integration Principles
- Partner with vendors who offer structured onboarding and training
- Develop clear treatment protocols
- Educate patients on expectations and value
- Integrate therapies into existing workflows
These fundamentals help ensure consistency, efficiency, and optimal clinical results.
Explore More on the EMTT-Shockwave Combined Approach
To further support your understanding, explore these related insights:
FAQ: EMTT-Shockwave Combined Approach
Which patients are best suited for an EMTT-Shockwave care plan?
Ideal candidates are patients with chronic tendinopathy/enthesopathy, persistent myofascial pain, degenerative joint pain, or delayed recovery who have not fully responded to standard conservative care. Best results are typically seen when therapy is paired with diagnosis-specific rehab and load management.
What are realistic expectations for patient response with an EMTT-Shockwave approach?
Most patients experience gradual improvement over the course of care, with early changes often seen in pain and tissue sensitivity, followed by functional gains. Outcomes vary based on chronicity, tissue quality, and adherence to rehab, but combination therapy is commonly used to support more consistent and sustained progress.
What does a practical EMTT-Shockwave treatment course look like in a busy clinic?
Many clinicians start with a short series (often 3–6 sessions) and re-evaluate after 2–3 visits for pain, function, and tissue tolerance. Treatments may be delivered same-day or alternating visits, then tapered or progressed based on response and goals.
How can EMTT-Shockwave be integrated with PT, injections, and orthobiologics?
Many practices use EMTT-Shockwave to help patients tolerate progressive loading and to support tissue conditioning pre- and post-procedure. When combined with injections or orthobiologics, clinicians typically coordinate timing around symptom flare windows and rehab phases to keep the overall plan coherent.
How are EMTT® and Shockwave therapy used together within a treatment plan?
Clinicians typically combine these modalities based on tissue type, depth, and treatment goals. Shockwave therapy is often used to provide targeted mechanical stimulation, while EMTT® supports the broader tissue environment, including bone and inflammatory processes. Many providers sequence or co-apply both within the same plan to reinforce treatment effects and support progression.
What are realistic expectations for patient response with an EMTT-Shockwave approach?
Most patients experience gradual improvement over the course of care, with early changes often seen in pain and tissue sensitivity, followed by functional gains. Outcomes vary based on chronicity, tissue quality, and adherence to rehab, but combination therapy is commonly used to support more consistent and sustained progress.
Watch Dr. Blatz: Onboarding and Integrating Shockwave and EMTT for Optimal Success
To see how this approach is applied in real-world practice, watch the full session:
Onboarding and Integrating Shockwave and EMTT for Optimal Success
In this webinar, Dr. Blatz covers:
- How he integrates EMTT® and Shockwave therapy into daily practice
- Patient selection and treatment strategies
- Lessons learned from real clinical cases
- Practical steps for successful implementation
Partner with CuraMedix for Clinical and Business Success
CuraMedix supports providers with:
- Evidence-based technologies developed by STORZ MEDICAL
- Comprehensive clinical education and onboarding
- Marketing support to help grow your practice
- A partnership focused on long-term success
Reach out, and we’ll connect you with an expert on our team who truly understands the best solution for your clinical practice needs.
About Dr. Brice Blatz, MD
Dr. Brice Blatz, MD, is a double board-certified in Family and Sports Medicine physician and founder of Maple Medical. He specializes in integrating advanced, non-invasive technologies, including Shockwave therapy and EMTT with orthobiologics to support tissue healing, restore function, and improve patient outcomes. His clinical expertise provides practical insight into how combination therapies can be successfully implemented in modern regenerative medicine practices.
